Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Novel markers of human ovarian granulosa cell differentiation toward osteoblast lineage: A microarray approach

M. Brązert, W. Kranc, P. Celichowski, K. Ożegowska, J. Budna-Tukan, M. Jeseta, L. Pawelczyk, M. Bruska, M. Zabel, M. Nowicki, B. Kempisty,

. 2019 ; 20 (5) : 4403-4414. [pub] 20190926

Language English Country Greece

Document type Journal Article

Under physiological conditions, human ovarian granulosa cells (GCs), are responsible for a number of processes associated with folliculogenesis and oogenesis. The primary functions of GCs in the individual phases of follicle growth are: Hormone production in response to follicle stimulating hormone (FSH), induction of ovarian follicle atresia through specific molecular markers and production of nexus cellular connections for communication with the oocyte. In recent years, interest in obtaining stem cells from particular tissues, including the ovary, has increased. Special attention has been paid to the novel properties of GCs during long‑term in vitro culture. It has been demonstrated that the usually recycled material in the form of follicular fluid can be a source of cells with stem‑like properties. The study group consisted of patients enrolled in the in vitro fertilization procedure. Total RNA was isolated from GCs at 4 time points (after 1, 7, 15 and 30 days of culture) and was used for microarray expression analysis (Affymetrix® Human HgU 219 Array). The expression of 22,480 transcripts was examined. The selection of significantly altered genes was based on a P‑value <0.05 and expression higher than two‑fold. The leucine rich repeat containing 17, collagen type I α1 chain, bone morphogenetic protein 4, twist family bHLH transcription factor 1, insulin like growth factor binding protein 5, GLI family zinc finger 2 and collagen triple helix repeat containing genes exhibited the highest changes in expression. Reverse‑transcription‑quantitative PCR was performed to validate the results obtained in the analysis of expression microarrays. The direction of expression changes was validated in the majority of cases. The presented results indicated that GCs have the potential of cells that can differentiate towards osteoblasts in long‑term in vitro culture conditions. Increased expression of genes associated with the osteogenesis process suggests a potential for uninduced change of GC properties towards the osteoblast phenotype. The present study, therefore, suggests that GCs may become an excellent starting material in obtaining stable osteoblast cultures. GCs differentiated towards osteoblasts may be used in regenerative and reconstructive medicine in the future.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023547
003      
CZ-PrNML
005      
20201214130345.0
007      
ta
008      
201125s2019 gr f 000 0|eng||
009      
AR
024    7_
$a 10.3892/mmr.2019.10709 $2 doi
035    __
$a (PubMed)31702034
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Brązert, Maciej $u Department of Gynecology, Obstetrics and Gynecological Oncology, Division of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 60‑535 Poznan, Poland.
245    10
$a Novel markers of human ovarian granulosa cell differentiation toward osteoblast lineage: A microarray approach / $c M. Brązert, W. Kranc, P. Celichowski, K. Ożegowska, J. Budna-Tukan, M. Jeseta, L. Pawelczyk, M. Bruska, M. Zabel, M. Nowicki, B. Kempisty,
520    9_
$a Under physiological conditions, human ovarian granulosa cells (GCs), are responsible for a number of processes associated with folliculogenesis and oogenesis. The primary functions of GCs in the individual phases of follicle growth are: Hormone production in response to follicle stimulating hormone (FSH), induction of ovarian follicle atresia through specific molecular markers and production of nexus cellular connections for communication with the oocyte. In recent years, interest in obtaining stem cells from particular tissues, including the ovary, has increased. Special attention has been paid to the novel properties of GCs during long‑term in vitro culture. It has been demonstrated that the usually recycled material in the form of follicular fluid can be a source of cells with stem‑like properties. The study group consisted of patients enrolled in the in vitro fertilization procedure. Total RNA was isolated from GCs at 4 time points (after 1, 7, 15 and 30 days of culture) and was used for microarray expression analysis (Affymetrix® Human HgU 219 Array). The expression of 22,480 transcripts was examined. The selection of significantly altered genes was based on a P‑value <0.05 and expression higher than two‑fold. The leucine rich repeat containing 17, collagen type I α1 chain, bone morphogenetic protein 4, twist family bHLH transcription factor 1, insulin like growth factor binding protein 5, GLI family zinc finger 2 and collagen triple helix repeat containing genes exhibited the highest changes in expression. Reverse‑transcription‑quantitative PCR was performed to validate the results obtained in the analysis of expression microarrays. The direction of expression changes was validated in the majority of cases. The presented results indicated that GCs have the potential of cells that can differentiate towards osteoblasts in long‑term in vitro culture conditions. Increased expression of genes associated with the osteogenesis process suggests a potential for uninduced change of GC properties towards the osteoblast phenotype. The present study, therefore, suggests that GCs may become an excellent starting material in obtaining stable osteoblast cultures. GCs differentiated towards osteoblasts may be used in regenerative and reconstructive medicine in the future.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a diferenciační antigeny $x biosyntéza $7 D000943
650    12
$a buněčná diferenciace $7 D002454
650    _2
$a ženské pohlaví $7 D005260
650    12
$a stanovení celkové genové exprese $7 D020869
650    12
$a regulace genové exprese $7 D005786
650    _2
$a folikulární buňky $x metabolismus $x patologie $7 D006107
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
650    _2
$a osteoblasty $x metabolismus $x patologie $7 D010006
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kranc, Wiesława $u Department of Anatomy, Poznan University of Medical Sciences, 60‑781 Poznan, Poland.
700    1_
$a Celichowski, Piotr $u Department of Histology and Embryology, Poznan University of Medical Sciences, 60‑781 Poznan, Poland.
700    1_
$a Ożegowska, Katarzyna $u Department of Gynecology, Obstetrics and Gynecological Oncology, Division of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 60‑535 Poznan, Poland.
700    1_
$a Budna-Tukan, Joanna $u Department of Histology and Embryology, Poznan University of Medical Sciences, 60‑781 Poznan, Poland.
700    1_
$a Jeseta, Michal $u Department of Obstetrics and Gynecology, University Hospital and Masaryk University, 62500 Brno, Czech Republic.
700    1_
$a Pawelczyk, Leszek $u Department of Gynecology, Obstetrics and Gynecological Oncology, Division of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 60‑535 Poznan, Poland.
700    1_
$a Bruska, Małgorzata $u Department of Gynecology, Obstetrics and Gynecological Oncology, Division of Infertility and Reproductive Endocrinology, Poznan University of Medical Sciences, 60‑535 Poznan, Poland.
700    1_
$a Zabel, Maciej $u Department of Human Morphology and Embryology, Division of Histology and Embryology, Wroclaw Medical University, 50‑368 Wroclaw, Poland.
700    1_
$a Nowicki, Michał $u Department of Histology and Embryology, Poznan University of Medical Sciences, 60‑781 Poznan, Poland.
700    1_
$a Kempisty, Bartosz $u Department of Anatomy, Poznan University of Medical Sciences, 60‑781 Poznan, Poland.
773    0_
$w MED00181650 $t Molecular medicine reports $x 1791-3004 $g Roč. 20, č. 5 (2019), s. 4403-4414
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31702034 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130344 $b ABA008
999    __
$a ok $b bmc $g 1595866 $s 1114223
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 5 $d 4403-4414 $e 20190926 $i 1791-3004 $m Molecular medicine reports $n Mol Med Rep $x MED00181650
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...